| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.
|
J Clin Hypertens (Greenwich)
|
2001
|
1.59
|
|
2
|
Abrupt cessation of clonidine administration: a prospective study.
|
Am J Cardiol
|
1978
|
1.53
|
|
3
|
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
|
Ann Intern Med
|
1994
|
1.44
|
|
4
|
Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study.
|
J Urol
|
1995
|
1.33
|
|
5
|
Racial differences in pressure, volume and renin interrelationships in essential hypertension.
|
Hypertension
|
1981
|
1.13
|
|
6
|
Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
|
Hypertension
|
1998
|
1.02
|
|
7
|
Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension.
|
Am J Cardiol
|
1976
|
1.00
|
|
8
|
Magnesium and potassium interrelationships, experimental and clinical.
|
Acta Med Scand Suppl
|
1981
|
0.99
|
|
9
|
Clonidine withdrawal.
|
Br J Clin Pharmacol
|
1979
|
0.96
|
|
10
|
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent.
|
Arch Intern Med
|
1978
|
0.95
|
|
11
|
Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril.
|
Clin Pharmacol Ther
|
1983
|
0.93
|
|
12
|
Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators.
|
Am J Cardiol
|
2001
|
0.89
|
|
13
|
Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature.
|
Arch Intern Med
|
1983
|
0.88
|
|
14
|
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
|
J Am Coll Cardiol
|
1998
|
0.87
|
|
15
|
Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
|
J Hum Hypertens
|
2010
|
0.86
|
|
16
|
Antihypertensive and renal effects of tienilic acid.
|
Postgrad Med J
|
1979
|
0.86
|
|
17
|
Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats.
|
Kidney Int
|
1979
|
0.85
|
|
18
|
Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension.
|
J Cardiovasc Pharmacol
|
1987
|
0.85
|
|
19
|
Renal functional and organic changes induced by salt and prostaglandin inhibition in spontaneously hypertensive rats.
|
Nephron
|
1980
|
0.84
|
|
20
|
Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group.
|
J Clin Pharmacol
|
1995
|
0.84
|
|
21
|
The effects of salt and meclofenamate administration on the hypertension of spontaneously hypertensive rats.
|
Clin Exp Hypertens
|
1980
|
0.84
|
|
22
|
Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences.
|
Arch Intern Med
|
1977
|
0.83
|
|
23
|
Withdrawal of antihypertensive therapy.
|
JAMA
|
1978
|
0.81
|
|
24
|
Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study.
|
Am J Hypertens
|
2001
|
0.81
|
|
25
|
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studies.
|
Clin Exp Hypertens
|
1999
|
0.81
|
|
26
|
Why hypertension is so prevalent in the elderly-and how to treat it.
|
Geriatrics
|
1976
|
0.80
|
|
27
|
Direct renal hemodynamic effects of clonidine.
|
Arch Int Pharmacodyn Ther
|
1975
|
0.78
|
|
28
|
A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.
|
Clin Pharmacol Ther
|
2012
|
0.78
|
|
29
|
Long-term hemodynamic and metabolic effects of trimazosin in essential hypertension.
|
Clin Pharmacol Ther
|
1981
|
0.78
|
|
30
|
Hemodynamic effects of isometric exercise in normotensive and hypertensive subjects.
|
Angiology
|
1978
|
0.77
|
|
31
|
Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.
|
Am J Hypertens
|
1989
|
0.77
|
|
32
|
Lisinopril dose-response relationship in essential hypertension.
|
Br J Clin Pharmacol
|
1989
|
0.77
|
|
33
|
Hemodynamic changes induced by prolonged NaCl and DOCA administration in spontaneously hypertensive rats.
|
Angiology
|
1978
|
0.76
|
|
34
|
Effectiveness of doxazosin in systemic hypertension.
|
Am J Cardiol
|
1989
|
0.76
|
|
35
|
Systemic and renal hemodynamic effects of bupicomide: a new vasodilator.
|
Am Heart J
|
1976
|
0.76
|
|
36
|
Effects of high salt intake and meclofenamate on arterial pressure and renal function in the spontaneously hypertensive rat.
|
Clin Sci (Lond)
|
1979
|
0.75
|
|
37
|
Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension.
|
J Clin Pharmacol
|
1992
|
0.75
|
|
38
|
Hemodynamic and metabolic effects of enalapril in patients with heart failure.
|
Clin Cardiol
|
1985
|
0.75
|
|
39
|
Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.
|
Am Heart J
|
1999
|
0.75
|
|
40
|
Captopril stimulation of differential renins in renovascular hypertension.
|
Hypertension
|
1983
|
0.75
|
|
41
|
Systemic hemodynamic effects of bethanidine in essential hypertension.
|
Circulation
|
1975
|
0.75
|
|
42
|
Hemodynamic correlates of autonomic reflexes in patients with labile and fixed hypertension.
|
Clin Exp Hypertens
|
1981
|
0.75
|
|
43
|
Plasma renin activity in hypertension after renal homotransplantation.
|
Angiology
|
1974
|
0.75
|
|
44
|
Letter: Withdrawal of clonidine.
|
JAMA
|
1976
|
0.75
|
|
45
|
Experience with terazosin administered in combination with other antihypertensive agents.
|
Am J Med
|
1986
|
0.75
|
|
46
|
A comparative study of captopril and enalapril in patients with severe hypertension.
|
J Clin Pharmacol
|
1985
|
0.75
|
|
47
|
Effects of diet on exaggerated natriuresis in hypertension.
|
Clin Exp Hypertens
|
1981
|
0.75
|
|
48
|
Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertension.
|
Clin Exp Hypertens
|
1998
|
0.75
|
|
49
|
Factors influencing hematocrit response to testosterone in patients on chronic hemodialysis.
|
Proc Clin Dial Transplant Forum
|
1972
|
0.75
|
|
50
|
Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
|
J Cardiovasc Pharmacol
|
1980
|
0.75
|
|
51
|
Effects of amiloride on arterial pressure and renal function.
|
J Clin Pharmacol
|
1980
|
0.75
|
|
52
|
Direct renal hemodynamic effects of two vasodilators: diazoxide and acetylcholine.
|
Arch Int Pharmacodyn Ther
|
1975
|
0.75
|
|
53
|
The value of grip test as an index of autonomic function in hypertension.
|
Clin Cardiol
|
1982
|
0.75
|
|
54
|
Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD.
|
Clin Cardiol
|
1997
|
0.75
|
|
55
|
Comparison of the antihypertensive effectiveness of guanadrel and guanethidine.
|
Curr Ther Res Clin Exp
|
1976
|
0.75
|
|
56
|
Evaluation of a new disposable dialyzer (Gambro).
|
Proc Clin Dial Transplant Forum
|
1972
|
0.75
|
|
57
|
Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable angina.
|
J Clin Pharmacol
|
1995
|
0.75
|
|
58
|
Renal functional changes induced by prostaglandin E1 and indomethacin in the anesthetized dog.
|
Arch Int Pharmacodyn Ther
|
1978
|
0.75
|
|
59
|
Hemodynamic correlates of saralasin: responsiveness in hypertension.
|
Kidney Int Suppl
|
1979
|
0.75
|
|
60
|
Hemodynamic correlates of saralasin-induced arterial pressure changes.
|
Circulation
|
1978
|
0.75
|
|
61
|
Antihypertensive and metabolic effects of hydrochlorothiazide, amiloride-hydrochlorothiazide, and timolol.
|
J Clin Pharmacol
|
1983
|
0.75
|
|
62
|
Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitor.
|
Clin Cardiol
|
1985
|
0.75
|
|
63
|
The effect of renal vasodilation and hypotonic volume expansion on water excretion in dogs after anesthesia and surgery.
|
Life Sci
|
1977
|
0.75
|
|
64
|
Side effects of antihypertensive drugs.
|
Am Fam Physician
|
1974
|
0.75
|
|
65
|
The mechanism for the renal hemodynamic and tubular action of furosemide.
|
Arch Int Pharmacodyn Ther
|
1981
|
0.75
|
|
66
|
Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients.
|
Am Heart J
|
1983
|
0.75
|
|
67
|
Natriuresis and carbohydrate-induced antinatriuresis in fasted, hydrated hypertensives.
|
Proc Soc Exp Biol Med
|
1975
|
0.75
|